(Total Views: 367)
Posted On: 06/12/2019 1:16:23 PM
Post# of 86967
Re: Naplesbird #9364
Naplesbird, adding more would be a good idea, but only if you have the money to spare. Nothing has changed at all. In fact, it appears we are getting bigger and gearing up for huge demand.
This Catalent/Paragon deal is HUGE. You can see the connection to Merck in their management, and look at the number of facilities Catalent will now control (locations in several states). This new plant will specialize in nebulizers, vaporizers, and sprays but will produce a wide range of additional products. When proposed, the new facility was only intended to be about 150,000 square feet --- now it will be 200,000 square feet. Apparently they have anticipated the need for additional capacity. Imagine the expected revenue. A 1.2 billion dollar investment in new production capacity really speaks for itself.
The new facility is set up to be GMP complient both in the United States and in Europe. The facility is also early stage FDA approved so no one needs to guess where this is going.
Kgem
This Catalent/Paragon deal is HUGE. You can see the connection to Merck in their management, and look at the number of facilities Catalent will now control (locations in several states). This new plant will specialize in nebulizers, vaporizers, and sprays but will produce a wide range of additional products. When proposed, the new facility was only intended to be about 150,000 square feet --- now it will be 200,000 square feet. Apparently they have anticipated the need for additional capacity. Imagine the expected revenue. A 1.2 billion dollar investment in new production capacity really speaks for itself.
The new facility is set up to be GMP complient both in the United States and in Europe. The facility is also early stage FDA approved so no one needs to guess where this is going.
Kgem
(3)
(0)
